Form 4: iRhythm Director Talwalkar Receives RSU Grant
Director Equity Grant Disclosure
Director Abhijit Y. Talwalkar was granted 1,573 restricted stock units in iRhythm Holdings, Inc. as part of standard equity compensation.
Summary
- Director Abhijit Y. Talwalkar acquired 1,573 restricted stock units (RSUs) on May 27, 2026.
- Each RSU represents a contingent right to receive one share of iRhythm Holdings, Inc. (IRTC) common stock.
- The RSUs vest on the earlier of one year from the grant date or the date of the company's next annual meeting.
- Following this transaction, the director's total beneficial ownership is 21,872 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director equity compensation with no impact on company operations or financial strategy.
Positives
- Director equity alignment with shareholder interests through RSU grants.
- The transaction reflects standard corporate governance practices for board compensation.
Negatives
- None identified.
Risks
- Standard market risks associated with equity-based compensation and share price volatility.
Future Outlook
The RSUs are scheduled to vest on the earlier of one year from the grant date or the date of the company's next annual meeting.
Industry Context
StockSavvy.ai notes that this is a routine disclosure of director compensation, common among publicly traded medical technology companies to ensure board members maintain a vested interest in long-term company performance.
Comparison to Industry Standards
- The grant of RSUs to non-employee directors is consistent with standard compensation practices for mid-cap healthcare and medical device companies.
- The vesting schedule aligns with typical one-year cliff or annual meeting-based vesting cycles observed in the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | The director authorized company officers to file Section 16 reports on his behalf. | 05/26/2026 | Administrative efficiency in regulatory compliance. |
Stakeholder Impact
- Minimal impact on shareholders as this is a standard equity compensation event.
Next Steps
- Vesting of the 1,573 RSUs on the earlier of May 27, 2027, or the date of the next annual meeting.
Key Dates
| Date | Description |
|---|---|
| 05/26/2026 | Execution date of the Power of Attorney by Abhijit Y. Talwalkar. |
| 05/27/2026 | Date of the RSU grant transaction. |
| 05/29/2026 | Filing date of the Form 4 with the SEC. |
Keywords
iRhythm, IRTC, Form 4, Director Compensation, Equity Grant, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.